이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Henry Schein 과거 수익 실적

과거 기준 확인 1/6

Henry Schein의 수입은 연평균 -3.4%의 비율로 감소해 온 반면, Healthcare 산업은 수입이 연평균 5.6%의 비율로 증가했습니다. 매출은 연평균 6.9%의 비율로 증가해 왔습니다. Henry Schein의 자기자본이익률은 8.1%이고 순이익률은 2.8%입니다.

주요 정보

-5.9%

수익 성장률

-3.3%

EPS 성장률

Healthcare 산업 성장	8.5%
매출 성장률	6.4%
자기자본 수익률	7.3%
순이익	2.8%
최근 수익 업데이트	29 Jun 2024

최근 과거 실적 업데이트

Recent updates

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Apr 14

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Feb 28

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Oct 11

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Sep 23

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Aug 21

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Aug 01

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jul 09

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Jun 09

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

May 21

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

May 01

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Apr 10

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Feb 15

Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled

Jan 28

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jan 10

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Dec 11

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?

Nov 04

Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios

Aug 25

Henry Schein announces $400M increase to stock buyback plan

Aug 18

If EPS Growth Is Important To You, Henry Schein (NASDAQ:HSIC) Presents An Opportunity

Aug 09

Henry Schein Q2 2022 Earnings Preview

Aug 01

Be Wary Of Henry Schein (NASDAQ:HSIC) And Its Returns On Capital

Jul 04

수익 및 비용 분석

Henry Schein 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

NasdaqGS:HSIC 수익, 비용 및 수입 (USD Millions )
날짜	수익	수익	G+A 비용
29 Jun 24	12,487	352	3,106
30 Mar 24	12,451	388	3,015
30 Dec 23	12,339	416	2,956
30 Sep 23	12,693	445	2,903
01 Jul 23	12,598	458	2,820
01 Apr 23	12,528	478	2,799
31 Dec 22	12,647	538	2,771
24 Sep 22	12,607	638	2,732
25 Jun 22	12,718	650	2,747
26 Mar 22	12,655	646	2,702
25 Dec 21	12,401	631	2,634
25 Sep 21	12,236	626	2,581
26 Jun 21	11,898	606	2,484
27 Mar 21	10,615	438	2,294
26 Dec 20	10,119	403	2,086
26 Sep 20	9,622	591	2,188
27 Jun 20	9,291	585	2,203
28 Mar 20	10,054	713	2,351
28 Dec 19	9,986	701	2,358
28 Sep 19	9,789	488	2,301
29 Jun 19	9,636	444	2,278
30 Mar 19	9,504	438	2,238
29 Dec 18	9,418	431	2,217
29 Sep 18	10,263	304	2,319
30 Jun 18	11,069	352	2,384
31 Mar 18	11,812	377	2,460
30 Dec 17	8,883	293	2,072
30 Sep 17	12,264	554	2,504
01 Jul 17	11,968	550	2,468
01 Apr 17	11,782	534	2,440
31 Dec 16	11,572	507	2,409
24 Sep 16	11,302	498	2,366
25 Jun 16	11,122	492	2,336
26 Mar 16	10,879	489	2,296
26 Dec 15	10,630	479	2,238
26 Sep 15	10,481	482	2,219
27 Jun 15	10,419	469	2,215
28 Mar 15	10,405	467	2,202
27 Dec 14	10,371	466	2,196
27 Sep 14	10,196	457	2,147
28 Jun 14	9,921	450	2,079
29 Mar 14	9,697	442	2,025
28 Dec 13	9,561	432	1,979

양질의 수익: HSIC 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: HSIC 의 현재 순이익 이익률 (2.8%) 작년보다 낮습니다 (3.8%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: HSIC 의 수입은 지난 5년 동안 매년 3.4% 씩 감소했습니다.

성장 가속화: HSIC 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.

수익 대 산업: HSIC 은 지난 1년 동안 마이너스 수익 성장( -27.8% )을 기록하여 Healthcare 업계 평균( 15.1% ).

Henry Schein 과거 수익 실적

과거 기준 확인 1/6

주요 정보

최근 과거 실적 업데이트

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. to Report Q2, 2024 Results on Aug 06, 2024

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Recent updates

Henry Schein, Inc.'s (NASDAQ:HSIC) Popularity With Investors Is Clear

Henry Schein, Inc.(NasdaqGS:HSIC) dropped from FTSE All-World Index (USD)

Price target decreased by 7.7% to US$73.27

Insider recently sold US$1.5m worth of stock

Insider notifies of intention to sell stock

Henry Schein (NASDAQ:HSIC) Will Be Hoping To Turn Its Returns On Capital Around

Consensus EPS estimates fall by 12%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Time To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

Henry Schein, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Market Participants Recognise Henry Schein, Inc.'s (NASDAQ:HSIC) Earnings

Henry Schein: Acquisition Strategy Isn't Pulling Its Economic Weight

Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority interest in TriMed, Inc.

Insider recently sold US$478k worth of stock

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Full year 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. Presents Comprehensive Lineup of Solutions At the 2024 Chicago Dental Society Mid Winter Meeting

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc.

Henry Schein Appoints Carole T. Faig as New Independent Director

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. announced delayed 10-Q filing

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority stake in Shield HealthCare, Inc.

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire a majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired a majority stake in Large Practice Sales LLC.

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Henry Schein, Inc. to Report Q2, 2023 Results on Aug 07, 2023

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Insider recently sold US$835k worth of stock

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Executive Vice Chairman & President notifies of intention to sell stock

Executive VP & COO notifies of intention to sell stock

Executive VP recently sold US$1.9m worth of stock

Executive VP notifies of intention to sell stock

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

Henry Schein, Inc. Provides Sales Guidance for the Fiscal Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) agreed to acquire SIN - Sistema de Implante Nacional S.A. from Southern Cross Group.

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Independent Director recently sold US$148k worth of stock

Senior VP & Chief Legal Officer notifies of intention to sell stock

Independent Lead Director recently sold US$504k worth of stock

Independent Lead Director notifies of intention to sell stock

Independent Director recently sold US$923k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Henry Schein, Inc. Reports Impairment Charge on Intangible Assets for the Fourth Quarter Ended December 31, 2022

Now 25% undervalued

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein, Inc. (NasdaqGS:HSIC) announces an Equity Buyback for $400 million worth of its shares.